Use of NMBA and reversal agent during thyroid surgery with intraoperative neuromonitoring

• 영문명: Use of NMBA and reversal agent during thyroid surgery with intraoperative neuromonitoring
• 발행기관: 대한신경모니터링학회
• 저자명: Leerang Lim
• 간행물 정보: 『Journal of Neuromonitoring & Neurophysiology』Vol.3 No.1, 19~24쪽, 전체 6쪽
• 주제분류: 의약학 > 일반외과학
• 파일형태: PDF
• 발행일자: 2023.05.31

영문 초록

Neuromuscular blocking agent (NMBA) provides adequate muscle relaxation for intubation and surgery, but their use can interfere with the interpretation of intraoperative neuromonitoring (IONM) signals. Various strategies for the use of NMBA during thyroid surgery with IONM have been proposed for both safe anesthesia and surgery, and adequate quality of IONM. Relaxant-free anesthesia or use of succinylcholine is not recommended as a routine use due to the potential of fatal complications such as laryngeal injury or malignant. Instead, the use of a single dose of rocuronium for intubation with or without a reversal agent has been widely adapted. Though spontaneous recovery of neuromuscular blockade can be achieved without a reversal agent, use of a reversal agent can shorten the time for adequate IONM. Both neostigmine and Sugammadex can be used to reverse the neuromuscular blockade. Neostigmine reverses all types of non-depolarizing NMBA, but can accompany systemic cholinergic effect, and is not effective to deep or higher level of blockade. Sugammadex only reverses the effect of aminosteroid NMBAs, but effective to all levels of blockade. Overall, appropriate strategies for the use of NMBAs and reversal agents are needed to ensure effective IONM without increasing the risk of nerve injury during surgery.

목차

Introduction

NMBAs and Their Reversal Agents

Use of NMBA during Thyroid Surgery

Strategies for Using NMBA and Reversal Agent for IONM during Thyroid Surgery

Conclusion

Funding

Conflict of Interest

ORCID

References

키워드

Neuromuscular blocking agents Intraoperative neurophysiologic monitoring Thyroidectomy Neostigmine Sugammadex